Rosso

What Rosso does

Rosso, a brand operated under Ema Health S.r.l. (legal entity in Italy), is a digital health platform for blood and plasma donation. Founded in 2023 by Chiara Schettino and Filippo Toni and headquartered in Mercogliano with operational offices in Milano and Lucca, the company operates a consumer-facing mobile application (iOS and Android) that enables Italian donors to check eligibility via a 30-question in-app quiz, book donations at preferred collection centers in approximately 30 seconds, track personal donation history, and receive automated reminders for next eligible donation dates.

The underlying technology spans two products: the Rosso consumer app and EmaOS, a B2B platform for blood collection centers and donor associations that handles reservations, donor records, and scheduling. The platform targets three customer segments: individual blood and plasma donors (primary), corporate employers via the Corporate Life Savers program, and collection centers/donor associations via EmaOS. Distribution is mobile-app-first with app store presence and a web app, supplemented by B2B enterprise sales for the corporate program.

The business model is not explicitly disclosed. The consumer app is offered free of charge, while monetization is implied to flow from B2B channels — Corporate Life Savers enterprise engagements and EmaOS licensing to collection centers — though pricing structures, contract values, and revenue figures are not publicly available. The company is GDPR-compliant and processes sensitive health data under EU regulatory frameworks. As of mid-2026, Rosso reports 10,000+ monthly active donors, a team of 25+ people, and €3M in cumulative disclosed funding led by 360 Capital with Cassa Depositi e Prestiti and Angelini.

Name

Rosso

Legal name

Ema Health S.r.l.

Website

https://donarosso.it

Company type

Private

Founded year

2023

Operating status

Operating

Headcount range

1–10 employees

Short description

Rosso is an Italian digital health platform operating a mobile app and B2B software (EmaOS) that connects blood and plasma donors to collection centers, corporate employers, and donor associations across Italy.

Ownership category

akta.pro rank

Product category

Blood Donation Management Software

NAICS

Blood and Organ Banks (621991)

akta.pro primary industry

Plasma Collection & Donor Services (Plasmapheresis Centers) (HLAIAHAH)

akta.pro secondary industries

Blood, Organ & Tissue Donation Organizations (BPAGACAJ), Patient Recruitment, Site Feasibility & Trial Enablement CROs (HLAGAAAI)

Keywords

• Blood donation booking
• Plasma donation app
• Donor management platform
• Blood collection software
• Transfusion medicine infrastructure

Headquarters

HQ city

Milano

HQ country

Italy

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B and B2C

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

1. App Services: Free mobile app for individual donors to discover eligibility, book donations, and track history. Revenue model not explicitly disclosed - likely subscription/licensing from B2B segment or data monetization within regulatory compliance.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels4 records

Core offering

Rosso develops a mobile application (iOS/Android) and web platform that enables Italian users to discover blood and plasma donation eligibility, book donation appointments at collection centers in approximately 30 seconds, and track their personal donation history with automated reminders for recurring donations. Through its parent EmaHealth, Rosso also offers EmaOS, a unified backend platform for blood collection centers and donor associations managing reservations, donor records, and scheduling, plus a Corporate Life Savers program enabling Italian companies to run employee blood donation initiatives.

Product overview

Rosso is a digital health platform for blood and plasma donation in Italy, consisting of a consumer-facing mobile application (Rosso) and an enterprise-grade platform (EmaOS) for collection centers and donor associations. The Rosso app enables donors to check eligibility, book appointments in 30 seconds, and track their donation history. EmaOS serves as the backend infrastructure for managing reservations, donors, and schedules. The Corporate Life Savers program extends the platform to enterprise clients, enabling corporate blood donation initiatives.

Differentiator

Problem solved

Functional benefit

Brands

• EmaOS: A single platform for reservations, donors and scheduling for blood collection centers and donor associations.

Products and services

• Rosso App Free mobile and web application for Italian blood and plasma donors to check eligibility via an anonymous 30-question quiz, book appointments in 30 seconds at preferred collection centers, track donation history, and receive reminders for next eligible donation.
• EmaOS Enterprise platform for blood collection centers and donor associations providing a single system for managing reservations, donor records, and appointment scheduling across the Italian transfusion medicine supply chain.
• Corporate Life Savers

Quantifiable outcome

• One donation can save up to three lives

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• FIDAS: Second major Italian blood donor association federation, with affiliated local donor groups across the country. Directly comparable to AVIS as an institutional competitor and potential B2B partner or blocker for Rosso's EmaOS rollout.
• Haemonetics: Global blood management company providing plasma collection software and donor management technology to plasma centers. Comparable to EmaOS in serving plasmapheresis centers, the specific donor segment Rosso prioritizes.
• AVIS (Associazione Volontari Italiani del Sangue): Italy's largest blood donor association with millions of members and direct institutional relationships with the SSN. It is the dominant incumbent that Rosso must convince donors and collection centers to route through, and could itself launch a competing digital platform.
• Octapharma Plasma: One of the world's largest plasma collection operators with its own donor apps and scheduling systems. Comparable as a vertically integrated plasma collection incumbent whose digital tooling competes with Rosso's plasma-booking proposition.
• CSL Plasma: Global plasma collection network operated by CSL Behring, with proprietary donor scheduling and loyalty applications. Relevant comparable as a plasma-specific incumbent building consumer-facing donor tech at global scale.
• WellSky (Blood Bank / Blood Centers division): Large US healthcare software vendor with a dedicated blood bank and donor management suite sold to hospitals and centers. Comparable as a more mature, scaled competitor to EmaOS for transfusion medicine workflow software.
• Grifols: Global plasma-derived therapies company operating one of the largest plasma donor networks with its own donor management platforms. Comparable as a plasma-category incumbent with consumer-facing donor digital infrastructure.

Regional players

• Vitalant: One of the largest US nonprofit blood collection organizations operating donor scheduling and recruitment tools across hundreds of centers. Comparable as a donor-centric collection operator whose digital platform parallels Rosso's EmaOS + Rosso consumer layer.

Direct peers

• InVita (formerly Hemasoft / Blood Bank Computer Systems): US-based supplier of blood and plasma management software (recruitment, donor scheduling, inventory) to blood centers and hospitals. Closest international comparable to EmaOS as a B2B platform for collection centers and donor associations.
• BloodHub: US-focused blood supply chain and donor management SaaS used by blood centers. Comparable to EmaOS in serving the operational and scheduling layer of transfusion medicine.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/Donarosso-61559058917504
• LinkedInlinkedin.com/company/donarosso

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds3 records

Investors11 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Rosso